National HealthCare Corporation
AMEX:NHCMedical - Care Facilities
+$1.33 today
- Market cap
- $3.16B
- Beta
- 0.67
- P/E (TTM)
- 24.2
- EPS (TTM)
- $7.96
- Dividend yield
- 1.33%
Volume 0.10M
Average 0.12M
NHC Investing Cash Flow
Net cash used in or generated by investments in assets, acquisitions, and securities.
National HealthCare CorporationAMEX: NHC
Investing Cash Flow · Q3 FY2026 · quarter ended Sep 2026
Investing cash flow turns negative
Q3 FY2026 investing cash flow was -$556.89M, compared with $1.98M a year earlier. Trailing-twelve-month investing cash flow was -$671.38M. Over 3 fiscal years it compounded at +78.3% a year.
Context
- Investing cash flow amounted to 2.2% of revenue in FY2025, down 16.0 pp from a year earlier.
- Investing cash flow grew in size in 2 of the last 3 fiscal years.
What to watch
Whether quarterly investing cash flow holds near -$556.89M or moves back toward the trailing-twelve-month quarterly average of -$167.85M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Investing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (33.86M) USD
- Year-over-year change
- +85.7%
| Period | Period end | Investing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (33.86M) | +85.7% |
| FY2024 | 2024-12-31 | (236.69M) | -1247.3% |
| FY2023 | 2023-12-31 | (17.57M) | -193.9% |
| FY2022 | 2022-12-31 | (5.98M) | +90.9% |
| FY2021 | 2021-12-31 | (65.89M) | — |
Investing Cash Flow vs competitors
How NHC compares with its peers on the latest reported figures
- NHC's LTM Sep 2026 investing cash flow of $671.38M is the 4th largest of the 10 companies compared; the peer median is $190.63M.
- Its year-over-year change of +1961.4% is the highest of 10, against a peer median of +22.0%.
- Investing cash flow amounts to 42.4% of revenue for NHC, versus a peer median of 8.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $986.08M | +365.7% | +24.2% | 239.4% | |
| LTM Jun 2026 | $824.6M | +19.7% | +6.8% | 13.3% | |
| LTM Jun 2026 | $680.15M | +22.0% | +40.2% | 12.4% | |
| LTM Sep 2026 | $671.38M | +1961.4% | +78.3% | 42.4% | |
| LTM Sep 2026 | $239.47M | -56.9% | +89.1% | 8.1% | |
| LTM Oct 2026 | $190.63M | +771.3% | -4.1% | 7.1% | |
| LTM Mar 2026 | $183.05M | +88.0% | +111.1% | 17.9% | |
| LTM Jun 2026 | $96.21M | +59.8% | -0.0% | 3.7% | |
| LTM Jun 2026 | $48.01M | -86.5% | -32.7% | 3.3% | |
| LTM Mar 2026 | $3.12M | -44.2% | -48.3% | 0.3% | |
| Peer median (excluding NHC) | $190.63M | +22.0% | +6.8% | 8.1% | |
Competitors are the stored peer set for NHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 139.09M | 19.98M | 65.29M | 102.09M | 122.61M |
| Depreciation & Amortization | 40.67M | 40.49M | 42.03M | 41.99M | 44.92M |
| Deferred Income Tax | (6.29M) | 6M | 5.77M | 17.94M | 6.48M |
| Stock-Based Compensation | 2.62M | 2.61M | 2.78M | 4.16M | 4.4M |
| Change in Working Capital | (40.74M) | (73.7M) | 17.4M | (25.72M) | 33.4M |
| Accounts Receivables | 4.09M | (3.86M) | (8.56M) | (26.44M) | (3.68M) |
| Inventory | 199K | 1.49M | (298K) | (599K) | 1.24M |
| Accounts Payables | (2.08M) | (5.53M) | 2.24M | 6.3M | (2.73M) |
| Other Working Capital | (42.94M) | (65.8M) | 24.02M | (4.98M) | 38.55M |
| Other Non-Cash Items | (72.95M) | 13.37M | (22.05M) | (33.15M) | (26.72M) |
| Operating Cash Flow | 62.39M | 8.74M | 111.22M | 107.3M | 185.08M |
| Capital Expenditures | (39.4M) | (30.2M) | (27.9M) | (27.6M) | (36.45M) |
| Acquisitions (Net) | (29.06M) | 0 | (7.36M) | (228.1M) | (5.63M) |
| Purchases of Investments | (108.19M) | (33.79M) | (29.5M) | (35.06M) | (65.19M) |
| Sales of Investments | 101.92M | 49.96M | 47.4M | 51.97M | 72.89M |
| Other Investing Activities | 8.84M | 8.05M | (201K) | 2.09M | 512K |
| Investing Cash Flow | (65.89M) | (5.98M) | (17.57M) | (236.69M) | (33.86M) |
| Debt Repayment | (4.42M) | (4.7M) | (4.99M) | 136.14M | (97M) |
| Common Stock Issued | 3.44M | 2.11M | 313K | 14.27M | 14.21M |
| Common Stock Repurchased | (836K) | (9.9M) | (2.48M) | (13.5M) | (14.73M) |
| Dividends Paid | (32.03M) | (34.6M) | (35.56M) | (36.96M) | (38.7M) |
| Other Financing Activities | (1.42M) | (554K) | 169K | 402K | 265K |
| Financing Cash Flow | (35.26M) | (47.64M) | (42.55M) | 100.34M | (135.96M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (38.76M) | (44.88M) | 51.1M | (29.05M) | 15.27M |
| Free Cash Flow | 23M | (21.46M) | 83.32M | 79.7M | 148.63M |
National HealthCare Corporation
AMEX:NHC
Intrinsic Alpha fair value
Locked
Current Price
$201.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.